Serum Institute of India: COVOVAX (Novavax formulation)
Vaccine Type: Protein Subunit
Vaccine Trial & Approval Tracker
This vaccine is approved.
Phase 1: 0 Trials
There are no trials for this phase.
Phase 2: 3 Trials
-
NCT05546502
-
CTRI/2021/02/031554
India -
NCT05515042
South Africa
Phase 3: 4 Trials
-
NCT05433285
Indonesia -
NCT05546502
-
CTRI/2022/04/042017
India -
CTRI/2021/02/031554
India
This vaccine is the same formulation as the Novavax vaccine (NVX-CoV2373)
Registered Trials
-
NCT05433285
Phase 3Indonesia
Total Enrollment: 4,050
Official Trial Registration:
-
CTRI/2022/04/042017
Phase 3India
Total Enrollment: 372
Official Trial Registration:
-
NCT05546502
Phase 2/3Total Enrollment: 1,050
Official Trial Registration:
-
CTRI/2021/02/031554
Phase 2/3India
Total Enrollment: 1,600
Official Trial Registration:
-
NCT05515042
Phase 2South Africa
Total Enrollment: 750
Official Trial Registration: